GSK takes billion-dollar drug fight with Gilead to top AIDS meeting

LONDON, June 20 (Reuters) - GlaxoSmithKline is taking its fight with Gilead Sciences for dominance of the HIV market to the world's leading AIDS conference next month by showcasing detailed results from its new two-drug treatment.